Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diagnosis, Computer-Assisted × Dermatologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 6 Thoracic 2 Other neoplasm 1 Dermatologic 1 Breast 1

Conditions

Melanoma 1 Disease 1

Interventions

pembrolizumab 295 Nivolumab 263 Ipilimumab 236 Cyclophosphamide 173 aldesleukin 132 Interleukin-2 95 fludarabine phosphate 92 trametinib 78 fludarabine 74 dabrafenib 69 Radiotherapy 69 Dacarbazine 68 Temozolomide 66 Biopsy 64 Vemurafenib 61 Radiosurgery 48 Imiquimod 48 Bevacizumab 47 Magnetic Resonance Spectroscopy 45 Blood Specimen Collection 44 sargramostim 43 Aminolevulinic Acid 43 Specimen Handling 42 3-ingenyl angelate 42 Peripheral Blood Stem Cell Transplantation 41 Paclitaxel 40 Cisplatin 40 Carboplatin 39 cemiplimab 38 atezolizumab 37

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06221397 2026-03-16

LEGIT_MC_EVCDA

AI Labs Group S.L

105 enrolled 15 charts

Disease, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡